US Patent 7345069 Oxidative activation and episulfonium ion-mediated DNA alkylation-based anticancer

Patent 7345069 was granted and assigned to Wisconsin Alumni Research Foundation on March, 2008 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Wisconsin Alumni Research Foundation

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

73450690

Patent Inventor Names

Ben Shen0

Date of Patent

March 18, 2008

Patent Application Number

110979720

Date Filed

April 1, 2005

Patent Primary Examiner

‌

Bruck Kifle

Patent abstract

The present invention relates to TG-25 and/or analogs thereof and their use of TG-25 in the treatment of cancer. TG-25 inhibits the growth of prostate cells by inhibiting DNA synthesis, more particularly by DNA cleavage.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7345069 Oxidative activation and episulfonium ion-mediated DNA alkylation-based anticancer

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API